Explore evidence

Knowledge levels at Phase-4 were higher than at Phase-2 for all domains except 'Pap Smears'.

Nigeriacancer du col de l'utéruspublished 2022BMC public healthPubMeddocument of 13 observations

68.8 %The overall screening accuracy was 68.8%.

Nigeriacancer du col de l'utérusobserved October 2020 to July 2021published 2023Reproductive healthPubMeddocument of 9 observations

8 %Among 7,682 cancers treated among Lagos residents, cervical cancer accounted for 8%.

Nigeriacancer du col de l'utéruspublished 2022JCO global oncologyPubMeddocument of 12 observations

90.3 %The respondents were highly open to cervical cancer vaccination (90.3%).

Nigeriacancer du col de l'utérusobserved April 2021published 2024The Pan African medical journalPubMeddocument of 8 observations

59 %Among cervical cancer cases recorded by the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018, 59% of those detected clinically were assigned to palliative care.

Nigeriacancer du col de l'utérusobserved 2016 to 2018published 2025Cancer causes & control : CCCPubMeddocument of 9 observations

44 %44% of suspected cervical cancer cases were referred for advanced care in Nigeria.

Nigeriacancer du col de l'utérusAfrica CDCdocument of 52 observations

2.9 %Only 2.9% of the respondents had adequate knowledge of risk factors for cervical cancer.

Nigeriacancer du col de l'utéruspublished 2020The Pan African medical journalPubMeddocument of 7 observations

53.9 %Among female undergraduates in a tertiary institution in south eastern Nigeria, 53.9% were aware of the cervical cancer screening test.

Nigeriacancer du col de l'utéruspublished 2021Journal of preventive medicine and hygienePubMeddocument of 11 observations

29 %The overall knowledge of cervical cancer screening among the respondents was 29.0%.

Nigeriacancer du col de l'utérusobserved 2017published 2022The Pan African medical journalPubMeddocument of 7 observations

HPV16 was the most prevalent high-risk HPV genotype detected in cervical cancer tissues from Maiduguri, Nigeria, during 2013–2015.

Nigeriacancer du col de l'utérusobserved 2013-2015published 2019The Pan African medical journalPubMeddocument of 4 observations

342,000 deathsGlobally, cervical cancer causes 342,000 deaths annually.

Nigeriacancer du col de l'utéruspublished 2025European journal of medical researchPubMeddocument of 8 observations

6.7 aORIn the presence of high-risk HPV, community state type III (CST-III) was associated with high-grade squamous intraepithelial lesion or invasive cervical cancer with an adjusted odds ratio of 6.7.

Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesion · high-risk human papillomavirusobserved 2020–2022published 2023BMC cancerPubMeddocument of 14 observations

16,173 womenAmong the 83,593 women screened, 16,173 (19%) received HPV DNA testing as their primary screening method.

Nigeriacancer du col de l'utérusobserved 2021published 2023BMC public healthPubMeddocument of 12 observations

18.2 %18.2% of the women cited not feeling susceptible to cervical cancer as a reason for not being screened.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

47.7 %47.7% of respondents had good knowledge of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2024Reproductive healthPubMeddocument of 16 observations

0.4 ng/mlThe mean squamous cell carcinoma antigen level in women without cervical cancer was 0.4 ± 0.2 ng/ml.

Nigeriacancer du col de l'utéruspublished 2025European journal of medical researchPubMeddocument of 8 observations

10,289 womenAbout 10,289 asymptomatic women aged 15–49 years living with HIV were screened for cervical cancer by primary case finders using VIA-based screening test.

Nigeriacancer du col de l'utérusobserved October 2020 to July 2021published 2023Reproductive healthPubMeddocument of 9 observations

7,968 deaths_per_yearNigeria reports 7,968 cervical cancer deaths annually.

Nigeriacancer du col de l'utérusAfrica CDCdocument of 52 observations

14.2 pointsThe health education intervention yielded a net gain of 14.2 points in knowledge about cervical cancer screening among adult women in Cross River State, Nigeria.

Nigeriacancer du col de l'utéruspublished 2023African journal of reproductive healthPubMeddocument of 4 observations

70.8 %Awareness of cervical cancer was 70.8% among women of a Catholic Parish in Nsukka Local Government Area of Enugu State, Nigeria.

Nigeriacancer du col de l'utéruspublished 2021The Pan African medical journalPubMeddocument of 8 observations

3 %VIA positivity was 3% among the general population in Nigeria.

Nigeriacancer du col de l'utérusAfrica CDCdocument of 52 observations

13,676 casesCervical cancer accounted for 13,676 new cases in Nigeria in 2022.

Nigeriacancer du col de l'utérusobserved 2022published 2026Rural and remote healthPubMeddocument of 21 observations

89.3 %The respondents were highly open to cervical cancer screening (89.3%).

Nigeriacancer du col de l'utérusobserved April 2021published 2024The Pan African medical journalPubMeddocument of 8 observations

86.3 %86.3% of the female postgraduate students at the University of Ibadan expressed their desire to be screened for cervical cancer if given the opportunity.

Nigeriacancer du col de l'utéruspublished 2024BMC women's healthPubMeddocument of 6 observations

97.6 %Most entries (42/43, 97.6%) focused on cervical cancer and human papillomavirus.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2026JMIR formative researchPubMeddocument of 7 observations